Double-strand RNA (dsRNA)-mediated posttranscriptional gene silencing, also known as RNA interference (RNAi), is a powerful tool to inhibit gene expression in several experimental model systems, including Arabidopsis, Caenorhabditis, and Drosophila. We previously described that the microinjection of Mos dsRNA into fully grown mouse oocytes results in the specific degradation of Mos mRNA in a timeand concentration-dependent manner. We report here a transgenic RNAi approach that is suitable to study gene function during mouse oocyte development and differentiation. The oocyte-specific Zp3 promoter was used to drive the expression of a long hairpin dsRNA (ϳ500 bp) targeting Mos mRNA. Transgenic founder animals appeared healthy, but while males were fertile, females were not, in accordance with the known Mos null phenotype. The amount of Mos mRNA in the transgenic F 1 females was reduced by Ͼ90%, whereas there was no decrease in the nontargeted tissue plasminogen activator (Plat) mRNA. Moreover, the maturation-associated increase in mitogen-activated protein (MAP) kinase activity was not observed, and the metaphase II eggs underwent spontaneous parthenogenetic activation, thus recapitulating the Mos null phenotype. This approach provides a powerful method to study the functions of any oocyte-synthesized gene during oocyte development and early embryogenesis.
Introduction
The holy grail of modern biology is to understand the function of each gene in the genome in every tissue/cell type. Disrupting a gene by homologous recombination is a standard approach to deduce gene function. Nevertheless, this approach is fraught with problems when studying gene function in oocytes, the female germ cells, since it can be difficult generating oocytes that are deficient in both alleles. For example, if the gene of interest is not oocyte-specific, the homozygous null mutant may be an embryonic lethal. Although Cre-lox technology can be used to study gene function in oocytes (de Vries et al., 2000) , the approach is not without its own intrinsic problems, and moreover, it is labor intensive.
An alternative method to study gene function in oocytes has been to use a transgenic antisense approach. Driving the expression of an antisense RNA to Plat (tissue plasminogen activator, tPA) with the oocyte-specific Zp3 promoter resulted in a reduction in Plat enzyme activity that ranged from 19 to 37% in hemizygous transgenic females to 60% in homozygous transgenic mice (Richards et al., 1993) . Although antisense transgenes have been used with various success in several different tissues (reviewed in Erickson, 1999) , the mechanism of their action was never fully understood. The recently discovered phenomenon of RNA interference (RNAi), a conserved cellular mechanism promoting sequence-specific mRNA degradation triggered by double-strand RNA (dsRNA), provides an explanation for the effect of antisense transgenes on the mRNA level and simultaneously allows the design of a more efficient posttranscriptional gene targeting system. The antisense RNA presumably pairs with the sense mRNA target to form a dsRNA that triggers the degradation of mRNA by the RNAi pathway. In fact, nuclear formation of dsRNA in antisense transgenes was described (Kim and Wold, 1985; Okano et al., 1991) long before the discovery of RNAi. The involvement of RNAi implies that the decrease of mRNA by antisense RNA depends on the efficient formation of the dsRNA trigger, its length, and the efficiency of the RNAi machinery in the tissue of interest. In fact, the length of the targeting sequence and high level of expression were previously recognized as important factors for successful antisense approach (Erickson, 1999) . Likewise, we have found that RNAi is at least a hundred times more efficient than antisense RNA in mouse oocytes, suggesting that the direct expression of dsRNA via a transgenic approach should induce much more efficient gene repression than a transgenic antisense RNA approach (Svoboda et al., 2000) .
Successful transgenic RNAi where the dsRNA trigger is expressed from a transgene has been reported in Caenorhabditis elegans (Tavernarakis et al., 2000) , Drosophila (Kennerdell and Carthew, 2000) , and Arabidopsis (Chuang and Meyerowitz, 2000) but not in mammals. Constructs expressing dsRNA usually contain an inverted repeat (IR) that is transcribed from a single promoter following the design of the first transgenic RNAi in C. elegans (Tavernarakis et al., 2000) , but dual promoter systems also work (Timmons and Fire, 1998; Wang et al., 2000) .
We report here the first successful use of transgenic RNAi in mammals in which the Mos gene was targeted by dsRNA expressed in a form of long hairpin RNA from the Zp3 promoter. Oocytes that express the transgene exhibit the phenotype of the Mos null mutant, namely, that the maturation-associated increase in mitogen-activated protein (MAP) kinase activity is not observed and the oocytes undergo spontaneous parthenogenetic activation at a high frequency. This approach provides a powerful method to study the functions of any oocyte-synthesized gene during oocyte development and early embryogenesis.
Materials and methods

Transgene preparation, generation of transgenic animals, and genotyping of transgenic mice
Construction of the plasmid carrying the transgenic construct expressing ϳ0.5 kb Mos RNA hairpin from the oocyte-specific Zp3 promoter (Fig. 1A) has been described elsewhere (Svoboda et al., 2001) . About 5 g of the plasmid were cut with AseI and AflII restriction endonucleases, and the products were resolved in a 0.7% agarose gel. The band corresponding to the expression cassette was purified from the gel by using Qiagen Gel Extraction Kit (Qiagen, CA) according to the manufacturer's instructions. DNA was eluted from Qiagen columns by using sterile MilliQ water, and its concentration was estimated spectrophotometrically. The DNA was diluted to 5 ng/l in sterile MilliQ water and submitted to the Transgenic and Chimeric Mouse Facility (TCMF) at the University of Pennsylvania to generate transgenic animals in B6SJLF1/J mice.
Southern blot and PCR analyses were used to identify transgenic mice. DNA was isolated by using proteinase K digestion followed by phenol extraction using TCMF's protocol (www.uphs.upenn.edu/genetics/core-facs/tcmf/). Southern blotting and hybridization were performed by standard methods (Ausubel et al., 1989) . For PCR screening, we used primers generating a 301-bp product that spanned the intron (Fig. 1A) . Genomic DNA (0.5 l containing ϳ100 -400 ng of DNA) was used in a 25-l PCR. Primer sequences were 5Ј-GCCTGGTGCTACGCCTGAATAA-3Ј for forward primer, and 5Ј-GTCAGCAGTAGCCTCATCATC-3Ј for reverse primer. PCR was performed with Amplitaq Gold (Applied Biosystems, CA) as follows: an initial denaturation step at 94°C for 15 min followed by 36 cycles of 94°C for 30 s, 58°C for 30 s, and 72°C for 30 s followed by 4°C until samples were removed.
Oocyte collection and in vitro maturation
Fully grown, germinal vesicle-intact (GV) mouse oocytes were obtained from 4-week-old female mice and freed of attached cumulus cells as previously described (Schultz et al., 1983) . The collection medium was bicarbonate-free minimal essential medium (Earle's salts) supplemented with polyvinylpyrrolidone (3 mg/ml) and 25 mM Hepes, pH 7.3. The denuded oocytes were matured in CZB medium (Chatot et al., 1989) in an atmosphere of 5% CO 2 in air at 37°C. For kinase assays (see below), some oocytes were removed and lysed individually after 18 h of culture. The remaining oocytes were further cultured to assess parthenogenetic activation. Images were captured by using a Leica DMIL inverted microscope and an Optronics MagnaFire CCD camera.
RNA isolation and semiquantitative RT-PCR
RNA was isolated from fully grown oocytes as described previously (Temeles et al., 1994) . Semiquantitative RT-PCR analysis of Mos and Plat was performed as described previously (Svoboda et al., 2000) . The same cDNA was also used to detect the expression of the spliced intron using primers and conditions described above.
Histone H1 and MAP kinase assay
Histone H1 and MAP kinase activities were assayed in single oocytes as described previously (Svoboda et al., 2000) . MAP kinase activity serves as an indirect measure of the MOS kinase (Svoboda et al., 2000) , and H1 kinase activity is a marker for CDK1/CYCB activity. Each of these activities increases during oocyte maturation, and H1 kinase serves as a biochemical marker for egg activation, since it decreases following activation (Moos et al., 1995) .
Results
Rationale for the experimental design
Mos codes for a serine-threonine kinase that functions upstream of MAP kinase. Mos mRNA is an abundant (ϳ10 4 transcripts in a fully grown, GV oocyte) dormant message that accumulates during oocyte growth and is not translated until resumption of meiosis. Mobilization of Mos mRNA results in the activation of MAP kinase, whose activity is required to maintain cell cycle arrest at metaphase II (Gebauer and Richter, 1997; Sagata, 1997) . The Mos model system provides two features that are useful to evaluate a transgenic RNAi approach. The first is that oocytes lacking the Mos gene do not arrest at metaphase II but undergo spontaneous parthenogenetic activation that is a readily observed phenotype as evidenced by emission of the second polar body, pronucleus formation, and cleavage (Colledge et al., 1994; Hashimoto et al., 1994; Hirao and Eppig, 1997) . Second, the amount of MAP kinase activity is a simple indirect assay for Mos mRNA level because Mos mRNA is not translated until oocytes resume meiosis. Moreover, the ability to measure MAP kinase activity in single oocytes/ eggs provides a simple way to assess the uniformity of the transgenic RNAi effect.
Classification of transgenic animals
Sixty-eight mice were obtained after pronuclear microinjection of one-cell embryos, and Southern blot and PCR analyses of tail DNA samples identified nine transgenic founder mice (Table 1) . Female founders were repeatedly mated for at least 3 months in an attempt to obtain F 1 transgenic progeny before sacrificing them to analyze their oocytes. Male founders were mated to CF-1 females, the progeny were tested for transmission of the transgene, and transgenic F 1 females were then screened for the Mos phenotype (Table 1) . The presence and expression of the transgene in F 1 animals was detected by RT-PCR (Fig. 1B) .
Analysis of founder animals
The transgenic founders appeared normal, except that two of the three transgenic females did not produce any progeny after repeated matings, in agreement with the previously reported subfertility of the Mos null mice where 40% of the females were infertile while the remainder were significantly subfertile (Hashimoto et al., 1994) .
The two founder females (H59 and H54), which did not produce any progeny, were sacrificed, and oocytes were collected and matured in vitro. These oocytes progressed to metaphase II and then underwent parthenogenetic activation at a high incidence when compared with a nontransgenic sibling (H70) (Fig. 2) . Also consistent with the Mos null Note. The C679 code is omitted when referring to transgenic founders in this paper. Copy number estimates are based on Southern blot analysis. Low copy, 2-3 copies are in a tandem array; high copy, Ͼ5 copies are likely in a tandem array. Transmission describes whether the transgene was transmitted to the next generation. * , Transgenic F 1 females were not obtained; no progeny, these two transgenic females did not produce any progeny after repeated mating for at least 3 months. Phenotype indicates if some phenotype (low MAP kinase activity, parthenogenetic activation) was present in founder females or in transgenic F 1 female progeny. N.D., not determined, because no female progeny were obtained from this male.
phenotype was that the maturation-associated increase in MAP kinase activity was not observed when some of these matured oocytes were analyzed (data not shown).
Analysis of F 1 transgenic females
Among the six transgenic males, five transmitted the transgene to the F 1 generation, and matured oocytes from F 1 female progeny of two of them, H13 and H53, displayed a low level of MAP kinase activity ( Fig. 3A; Table 1 ). This decrease in MAP kinase activity suggested an efficient targeting of Mos mRNA in these animals. Semiquantitative RT-PCR analysis of oocytes obtained from F 1 progeny of H13 and H53 revealed up to a 98% reduction of Mos mRNA (Fig. 4) . This reduction was specific, since there was no apparent decrease in the amount of the nontargeted Plat mRNA. The substantial reduction in Mos mRNA in these eggs correlated well with the observation that all the eggs obtained from H13 F 1 female progeny exhibited a very low level of MAP kinase and H1 kinase activities in MII eggs (Fig. 3) . Consistent with the low H1 kinase activity was that 84% of these eggs (38/45) underwent parthenogenetic activation following culture and either formed pronuclei (Fig.  5A) or cleaved to the two-cell stage or beyond (Fig. 5B) . In contrast, eggs obtained from nontransgenic littermates either remained at MII (12/16) (Fig. 5C ) or underwent fragmentation (Fig. 5D ) after 65 h in culture. We did not observe a dramatic incidence of fragmentation in transgenic animals (2/25) after such an extended culture. This differs from a previous report (75% fragmentation) (Colledge et al., 1994) and may reflect differences in the genetic backgrounds of strains used.
Compared with H13 female progeny, the amount of Mos mRNA in H53 F 1 female progeny was less (Fig. 4) and MAP kinase activity was not as low (19 vs 11%, P value Ͻ 0.01, t test). These eggs displayed no apparent decrease in H1 kinase and as expected did not undergo parthenogenetic activation (data not shown). Thus, only a small additional decrease in MAP kinase activity is sufficient to trigger parthenogenetic activation.
Discussion
The transgenic RNAi approach reported here should be a powerful method to study the function of any gene in the oocyte and has several advantages when compared with existing methods. The first advantage is that it is relatively simple, since it only entails generating transgenic mice in which the transgene is maintained in males that can be repeatedly mated to obtain enough transgenic females for subsequent analysis. This overcomes the common problem when the gene of interest has an embryonic lethal phenotype, thereby dictating the use of the more complicated Cre-lox approach. The highly efficient lentiviral vector approach, which doesn't entail pronucleus injection (Lois et al., 2002) , to generate transgenic mice may make this transgenic RNAi approach even simpler.
Another significant feature of this knockdown approach is that RNAi could generate a range of informative phenotypes that complements the "classical" gene knockout approach, since hypomorph phenotypes frequently provide critical insights into gene function. For example, an allelic series of mutations in Smad2 and Smad4 reveals a range of phenotypes in this signaling pathway (Vivian et al., 2002) . Moreover, a knockdown approach can unmask the existence of a threshold level of gene function required to observe a mutant phenotype. For example, we report here that oocytes from nonmosaic females in two transgenic lines (H13 and H53) exhibit a dramatic reduction in Mos mRNA, and yet these lines show markedly different phenotypes. The line that exhibits the greater decrease in Mos mRNA (H13) reveals a lower level of MAP kinase activity (11% when compared with controls, i.e., an 89% decrease) and also exhibits a relatively uniform and low level of H1 kinase activity, consistent with the observed high increase in the incidence of parthenogenetic activation. Although the other line (H53) also displays a significant reduction in MAP kinase (ϳ19% when compared with controls, i.e., an 81% decrease), there is no reduction in H1 kinase activity or any sign of parthenogenetic activation. These results reveal a threshold level of MAP kinase that must be present to maintain metaphase II arrest. Detecting thresholds provides insights into how a cellular switch may function (Ferrell, 1999a,b) . That modest changes in the expression of a gene can result in profound differences in outcome is highlighted by the observation that changes of ϳ50% in the levels of Oct-4 expression function as a developmental switch by regulating the fate of ES cells, e.g., higher levels lead to differentiation into primitive endoderm and mesoderm, intermediate levels lead to pluripotent stem cells, and reduced levels result in trophectoderm (Niwa et al., 2000) . By experimentally manipulating the level of expression of the hairpin RNA via differences in transgene number or promoter design, it should be possible to generate informative allelic series that will reveal insights into the gene's function.
There are two concerns that should be considered when expressing long dsRNA. First, expression of RNA that can form a hairpin can be compromised by activation of cryptic splicing sites and polyadenylation signals in the antisense sequence. Computational analysis and testing the antisense strand in an exon trapping system (Hamaguchi et al., 1992; Ozawa et al., 1993) may be helpful to avoid this problem. Second, cloning the inverted repeat for expression of long hairpin dsRNA is often difficult for reasons that remain poorly understood, but may be related to difficulty in replicating inverted repeat DNA (Tavernarakis et al., 2000; Svoboda et al., 2001) . A solution to this problem can be using an intron spacer that greatly enhances cloning and produces very efficient loop-less RNA hairpins (Kalidas and Smith, 2002; Smith et al., 2000; Wesley et al., 2001) . The transgenic RNAi approach described here is likely much more efficient than the previously reported transgenic antisense method. The transcript abundance for both Mos and Plat is similar, and yet the inhibitory effect observed in hemizygous oocytes is much stronger when Mos mRNA is targeted by RNAi than when Plat mRNA was targeted by antisense RNA. The difference in efficiency is likely underestimated. In the transgenic antisense study, the entire Zp3 promoter was used, and the Zp3 3Ј UTR and polyadenylation signal were present. Our construct uses a truncated version of this promoter, which, although it still exhibits oocyte-specific expression, may drive lower levels of expression due to the absence of particular regulatory elements. Moreover, our construct contains an SV40 early polyadenylation signal and the SV40 small intron. We have discovered recently that this construct exhibits about an order of magnitude lower expression compared with a construct with a different intron and SV40 late polyadenylation signal (data not shown).
Since Mos mRNA accumulates during oocyte growth and is not translated until resumption of meiosis, it is subject to RNAi throughout the growth phase. Thus, it is possible that the approach described here could only be applicable to similar types of maternally repressed mRNAs. We believe that this is most unlikely. In the female, MSY2 is an oocytespecific RNA-binding protein that is expressed throughout oocyte growth and is one of the most abundant proteins in oocytes, comprising 2% of total oocyte protein (Yu et al., 2001) . We have used a similar transgenic RNAi approach to target Msy2 and find that the amount of MSY2 protein is selectively reduced and that the female transgenic mice display a marked reduction in fertility (Yu, Hecht, and R.M.S., unpublished results) . Although this transgenic RNAi approach would be ineffective in studying genes in oocytes of primordial follicles in which the Zp3 promoter is not yet activated, using a primodial oocyte-specific promoter would circumvent this problem.
The oocyte is ideally suited for this transgenic RNAi approach that results in the expression of a long dsRNA. In contrast to somatic cells that typically undergo apoptosis when exposed to dsRNA Ͼ30 bp (Castelli et al., 1997; Der et al., 1997) , long dsRNA apparently does not trigger apoptosis in either oocytes or preimplantation embryos, which do contain the cell death machinery (Brison and Schultz, 1997; Jurisicova et al., 1998; Morita and Tilly, 1999) . Whether the approach can be translated to target genes in other cell types by using a tissue-specific promoter remains to be established. Of potential interest is that dsRNA can be expressed in somatic cells without apparently triggering apoptosis (de Wit et al., 2002; Gan et al., 2002; Kantarjian et al., 1985; Kim and Wold, 1985; Kramerov et al., 1985; Okano et al., 1991; Schmitt et al., 1986) . 
